MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 217 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q2 2023. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,200 | -50.7% | 6,320 | -38.7% | 0.01% | -62.2% |
| Q2 2023 | $128,116 | +49.5% | 10,307 | +68.5% | 0.04% | +37.0% |
| Q1 2023 | $85,713 | +119.8% | 6,118 | +459.7% | 0.03% | +35.0% |
| Q1 2022 | $39,000 | -70.9% | 1,093 | -60.0% | 0.02% | -76.7% |
| Q3 2021 | $134,000 | +14.5% | 2,733 | -2.4% | 0.09% | +16.2% |
| Q2 2021 | $117,000 | – | 2,800 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |